Henry Schein Inc. (NASDAQ:HSIC) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $182.30 and last traded at $182.26, with a volume of 96,296 shares traded. The stock had previously closed at $180.72.

A number of research analysts have issued reports on the stock. Barrington Research restated an “outperform” rating and set a $188.00 target price (up previously from $182.00) on shares of Henry Schein in a research report on Wednesday, May 4th. Vetr upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $176.75 price target on the stock in a research report on Monday, May 2nd. Credit Suisse Group AG reiterated a “hold” rating on shares of Henry Schein in a research report on Saturday, June 4th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $189.00 price target on the stock in a research report on Wednesday, May 4th. Finally, Leerink Swann reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, May 5th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $155.37.

The stock’s 50-day moving average is $175.06 and its 200-day moving average is $166.00. The firm has a market capitalization of $14.97 billion and a PE ratio of 31.21.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.02. The business earned $2.70 billion during the quarter, compared to the consensus estimate of $2.66 billion. During the same period last year, the firm earned $1.28 EPS. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, analysts forecast that Henry Schein Inc. will post $6.63 EPS for the current fiscal year.

In related news, insider Peter M. Mccarthy sold 1,158 shares of the business’s stock in a transaction that occurred on Thursday, May 12th. The shares were sold at an average price of $171.75, for a total transaction of $198,886.50. Following the completion of the transaction, the insider now owns 12,285 shares of the company’s stock, valued at $2,109,948.75. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Gerald A. Benjamin sold 9,991 shares of the business’s stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $175.08, for a total transaction of $1,749,224.28. Following the transaction, the executive vice president now directly owns 54,885 shares of the company’s stock, valued at approximately $9,609,265.80. The disclosure for this sale can be found here.

A number of institutional investors have recently modified their holdings of the stock. OppenheimerFunds Inc. purchased a new position in shares of Henry Schein during the fourth quarter valued at approximately $15,783,000. Mitsubishi UFJ Kokusai Asset Management CO. LTD. boosted its position in Henry Schein by 6.2% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 11,053 shares of the company’s stock worth $1,748,000 after buying an additional 648 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in Henry Schein by 18.2% in the fourth quarter. Daiwa Securities Group Inc. now owns 6,500 shares of the company’s stock worth $1,028,000 after buying an additional 1,000 shares in the last quarter. GSA Capital Partners LLP boosted its position in Henry Schein by 31.2% in the fourth quarter. GSA Capital Partners LLP now owns 16,819 shares of the company’s stock worth $2,661,000 after buying an additional 4,004 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Henry Schein by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 7,235,040 shares of the company’s stock worth $1,144,511,000 after buying an additional 190,450 shares in the last quarter.

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.